Meghan Zuck

Statistics

Publications

Citations

443

H-Index

Active since

2008

Affiliations

NovaBay Pharmaceuticals (United States)(Current)

University of Washington

University of California, Berkeley

Innsbruck Medical University

Center for Infectious Disease Research

Meghan Zuck is an author at NovaBay Pharmaceuticals (United States) specializing in microbiology, host-pathogen interactions, and infectious diseases.

Publications per year

2008–2021

Publications

Sensing of Bacterial Cyclic Dinucleotides by the Oxidoreductase RECON Promotes NF-κB Activation and Shapes a Proinflammatory Antibacterial State

Adelle P. McFarland, Shukun Luo, Fariha Ahmed-Qadri et al. · Immunity · 2017 · 121 citations · Full text

Life Sciences, Microbiology, Molecular Biology +12

Liver stage malaria infection is controlled by host regulators of lipid peroxidation

Heather S. Kain, Elizabeth K. K. Glennon, Kamalakannan Vijayan et al. · Cell Death and Differentiation · 2019 · 86 citations · Full text

Veterinary Medicine, Cell Biology, Infectious Diseases +16

Actin Recruitment to the Chlamydia Inclusion Is Spatiotemporally Regulated by a Mechanism That Requires Host and Bacterial Factors

Elizabeth Chin, Kelly R. Kirker, Meghan Zuck et al. · PLoS ONE · 2012 · 65 citations · Full text

Life Sciences, Cell Biology, Microbiology +16

Extrusions are phagocytosed and promote <i>Chlamydia</i> survival within macrophages

Meghan Zuck, Tisha Ellis, Anthony Venida et al. · Cellular Microbiology · 2016 · 56 citations

Life Sciences, Infectious Diseases, Microbiology +15

N,N-Dichloroaminosulfonic acids as novel topical antimicrobial agents

Eddy Low, Satheesh Nair, Timothy P. Shiau et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 23 citations

Medicine, Microbiology, Pharmacology +11

1–5 of 10